Protein News and Research

RSS

Proteins are complex molecules that are made up of amino acids. They can be found in every cell in the body, and carry out vital processes that keep human beings alive. Mutations in proteins can lead to a multitude of diseases, the most common being cancer.

Rapid Wound Healing in Jellyfish Offers Insights Into How Human Skin Repairs

Jocelyn Malamy first witnessed jellyfish cells "walk" toward each other to close a wound at the Marine Biological Laboratory a decade ago.

1 Jul 2026

Researchers Discover How Bacteria Use Powerful Molecular Motors to Spread Drug Resistance

Every year bacteria kill more than a million people worldwide through infections that no longer respond to antibiotics. In many cases, why those bacteria are so hard to stop comes down to their uniquely powerful structure.

1 Jul 2026

New Study Defines Molecular Features That Guide the Oncogenic Enzyme Called NSUN2

An RNA-modifying enzyme linked to cancer and neurological disorders selects its targets by recognizing specific RNA shapes and sequences, according to a study by UT Southwestern Medical Center researchers. The findings, published in Nature, define the molecular features that guide the enzyme, NSUN2, to the RNAs it modifies and could help researchers investigate how abnormal RNA modification contributes to disease.

1 Jul 2026

Researchers Identify Crucial Cell Death in Down Syndrome

Researchers at the Alzheimer's Center at Temple have identified evidence of a new form of cell death known as necroptosis in the brains of individuals with Down Syndrome, with the corresponding biomarkers providing new clues to potential treatment also for Alzheimer's and other neurodegenerative diseases.

1 Jul 2026

Sleep helps neural networks recover adaptive performance after absorbing daily life shocks

Every animal that has ever been studied closely, from the fruit fly to the philosopher, surrenders each day to a state that looks, from the outside, like a small rehearsal for death.

1 Jul 2026

New SRV2 Viral Vector Boosts CAR-T Cell Production Efficiency

A Korean research team has developed a new viral vector technology that significantly improves the production efficiency of next-generation cell and gene therapies known as CAR immune cell therapies, which are designed to recognize and destroy cancer cells.

1 Jul 2026

Chinese Researchers Map Greek Oregano Genome for Better Agriculture

Oregano belongs to the Lamiaceae family, which includes many aromatic and medicinal plants.

30 Jun 2026

New Study Explains How Blood Cancer Cells Invade the Lungs

Led by NYU Langone Health researchers, a new study shows how blood cancer cells enter the lungs, damage tissue, and cause severe breathing problems.

30 Jun 2026

University of Utah Study Identifies Arc Protein as Alzheimer's Driver

Alzheimer's disease is driven by a buildup of a toxic protein called Tau that kills neurons. As toxic Tau spreads to new regions of the brain, symptoms become worse and ultimately fatal.

30 Jun 2026

First Atomic Level Images Reveal Blueprint for Better RNA Drugs

RNA interference is a natural mechanism for living cells to control whether specific genes are being used or not.

30 Jun 2026

Mayo Clinic Scientists Discover Molecular Structures of Key Protein

After nearly four decades of research, Mayo Clinic scientists have revealed the molecular structures of protein kinase C beta (PKCβ), a key protein linked to cancer and neurological diseases.

29 Jun 2026

Single Nucleus RNA Sequencing Decodes Tomato Plant Early Stage Development

Seedling emergence is one of the most vulnerable stages in plant life. In darkness, seedlings undergo skotomorphogenesis, forming elongated hypocotyls and curved apical hooks that protect the shoot tip as it pushes through soil.

29 Jun 2026

Merck KGaA, Darmstadt, Germany, Agrees to Acquire Bio-Techne, Strengthening Leadership Position in Fast-Growing Life Sciences Markets

Merck KGaA, Darmstadt, Germany, a leading science and technology company, and Bio-Techne Corporation, a Minneapolis-based global provider of life science tools, analytical technologies, and consumables, today entered into a definitive agreement pursuant to which Merck KGaA, Darmstadt, Germany, will, subject to customary closing conditions, acquire Bio-Techne for US$73 per share in cash, representing a total enterprise value of approximately US$11.3 billion (EUR 9.9 billion), a 36% premium to Bio-Techne's one-month volume weighted average trading price.

From Bio-Techne 26 Jun 2026